Metastatic renal EAML is a rare disease. With mTOR inhibitor treatment
showing rather positive effect in an adequate therapeutic dose.
Vigilance and awareness of drug interactions is of an extreme
importance. These interactions can be overcome with proper drug or dose
changes.
Figure 1: Pharmacokinetic curve of temsirolimus and sirolimus before and
after dose adjustment.